Cardiovascular magnetic resonance imaging for assessment of cardiac thrombus.
Cardiac thrombus provides a substrate for embolic events and an indication for anticoagulant therapy. Cardiac magnetic resonance (CMR) imaging enables thrombus to be detected based on intrinsic tissue characteristics related to avascular tissue composition. Delayed enhancement CMR tissue characterization has been well validated for thrombus assessment using references of both pathology and clinical thromboembolic outcomes. Comparative studies have demonstrated CMR to yield improved thrombus detection compared to echocardiography, which typically detects thrombus based on anatomic appearance. Experimental studies have demonstrated the feasibility of targeted CMR contrast agents for assessing thrombus composition and chronicity. This review examines established and emerging literature on use of CMR for assessing cardiac thrombus.
Weill Cornell Medical College, New York, New York.
Parag
P
Goyal
Jonathan W
JW
Weinsaft
D003937:Diagnosis, Differential; D006331:Heart Diseases / Q000175:diagnosis*; D006801:Humans; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods*; D015203:Reproducibility of Results; D013927:Thrombosis / Q000175:diagnosis*
echocardiography; magnetic resonance imaging; thrombus